Fujita, Takuya
Tanabe Pharma Corporation (Japan)
4 papers on CoChatORCID 0000-0002-7724-6522
Most cited papers
- Verified
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation
Adipokines, Inflammation, and Metabolic DiseasesRedox biology and oxidative stress
Cited by 5,508
- Verified
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure
Granberg, K. L., Sakamaki, S., Larsson, N., Bergström, F., Fuchigami, R., Niwa, Y., Ryberg, E., Backmark, A., Kato, H., Miyazaki, S., et al. (2024) · Journal of Medicinal Chemistry
Pregnancy-related medical researchHeart Failure Treatment and Management
Cited by 26
- Verified
Generation of HepG2 Cells with High Expression of Multiple Drug-Metabolizing Enzymes for Drug Discovery Research Using a PITCh System
Negoro, R., Tasaka, M., Deguchi, S., Takayama, K., & Fujita, T. (2022) · Cells
Pharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms
Cited by 16
- Verified
Mesenchymal Stem Cells Promote IL-6 Secretion and Suppress the Gene Expression of Proinflammatory Cytokines in Contractile C2C12 Myotubes
Kono, Y., Kajita, H., Okada, T., Nakagawa, R., Fujita, T., & Konishi, S. (2022) · Biological and Pharmaceutical Bulletin
Muscle Physiology and DisordersMesenchymal stem cell research
Cited by 11
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free